Related references
Note: Only part of the references are listed.Treatment of diabetic rats with a peroxynitrite decomposition catalyst prevents induction of renal COX-2
Yu-Jung Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Chronic COX Inhibition Reduces Diabetes-Induced Hyperfiltration, Proteinuria, and Renal Pathological Markers in 36-Week B6-Ins2(Akita) Mice
Rania Nasrallah et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
Carla Q. Feitoza et al.
MOLECULAR MEDICINE (2008)
Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release
Yu-Jung Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Evidence for a role of transforming growth factor (TGF)-β1 in the induction of postglomerular albuminuria in diabetic nephropathy -: Amelioration by soluble TGF-β type II receptor
Leileata M. Russo et al.
DIABETES (2007)
Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats
Radko Komers et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat
Yu-Jung Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat
J Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney
J Quilley et al.
HYPERTENSION (2003)
Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney
J Quilley et al.
HYPERTENSION (2003)
Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats
K Kalantarinia et al.
KIDNEY INTERNATIONAL (2003)
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
K DiPetrillo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension
HF Cheng et al.
KIDNEY INTERNATIONAL (2002)
Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist
H Makino et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Prostaglandin H synthase and vascular function
ST Davidge
CIRCULATION RESEARCH (2001)
Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes
R Korners et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
